Twenty genes were found mutated orwith copy number alterations in at least five percent of three cancer cohortsand six of them (PHOX2A, NFYC, EST2, EIF2S1, SSRP1 and PARP1) associated withimpacted patient survival. This evidence concerns the gene NFYC and cancer.